Related Experiment Video
Updated: Jul 2, 2025
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Excitotoxicity and ALS: New therapy targets an old mechanism
Hannah Louise Smith1, Helena Chaytow1, Thomas Henry Gillingwater1
1Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK; Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh, Edinburgh, UK.
Abstract:
Excitotoxicity-induced cell death in motor neurons is a major therapeutic target for amyotrophic lateral sclerosis (ALS). Yan et al.1 present a novel compound to specifically disrupt extra-synaptic NMDAR complexes, extending the lifespan of the SOD1G93A ALS mouse and ameliorating cell death.
Insights
Researchers developed a new compound targeting motor neuron excitotoxicity in amyotrophic lateral sclerosis (ALS). This compound extended lifespan and reduced cell death in a mouse model, offering a potential new therapy for ALS.
Area of Science:
- Neuroscience
- Neurodegenerative Diseases
- Drug Discovery
Background:
- Excitotoxicity contributes to motor neuron death in amyotrophic lateral sclerosis (ALS).
- Targeting excitotoxicity is a key therapeutic strategy for ALS.
Purpose of the Study:
- To investigate a novel compound designed to disrupt extra-synaptic N-methyl-D-aspartate receptor (NMDAR) complexes.
- To evaluate the therapeutic potential of this compound in an ALS mouse model.
Main Methods:
- Administration of a novel compound targeting extra-synaptic NMDARs.
- Assessment of lifespan and motor neuron cell death in SOD1G93A ALS mice.
Main Results:
- The novel compound significantly extended the lifespan of SOD1G93A ALS mice.
- Treatment with the compound ameliorated motor neuron cell death.
Conclusions:
- Disrupting extra-synaptic NMDAR complexes is a viable therapeutic approach for ALS.
- The novel compound demonstrates promise for treating amyotrophic lateral sclerosis.
